FLG and Alzheimer disease: Baicalin and formononetin significantly upregulate the expression of filaggrin and loricrin, reduce TEWL, suppress mast cell infiltration, and ameliorate both epidermal disruption and modified Eczema Area and Severity Index (EASI) scores in AD mouse models (Wang L. et al., 2022; Zhou et al., 2023).